| 000 | 01455 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250514185201.0 | ||
| 264 | 0 | _c20040618 | |
| 008 | 200406s 0 0 eng d | ||
| 022 | _a0145-2126 | ||
| 024 | 7 |
_a10.1016/j.leukres.2003.08.010 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRubnitz, Jeffrey E | |
| 245 | 0 | 0 |
_aPhase II trial of cladribine and cytarabine in relapsed or refractory myeloid malignancies. _h[electronic resource] |
| 260 |
_bLeukemia research _cApr 2004 |
||
| 300 |
_a349-52 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 |
_aCladribine _xadministration & dosage |
| 650 | 0 | 4 |
_aCytarabine _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 |
_aLeukemia, Myeloid _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aRazzouk, Bassem I | |
| 700 | 1 | _aSrivastava, Deo Kumar | |
| 700 | 1 | _aPui, Ching-Hon | |
| 700 | 1 | _aRibeiro, Raul C | |
| 700 | 1 | _aSantana, Victor M | |
| 773 | 0 |
_tLeukemia research _gvol. 28 _gno. 4 _gp. 349-52 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.leukres.2003.08.010 _zAvailable from publisher's website |
| 999 |
_c14820479 _d14820479 |
||